FitzPatrick Margaret M
Insider CIK 1873879 · VTGN Director · ANTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | P Buy | 2026-09-01 | 2026-09-02 | 2,098 | $5.53 | $11.6K | 10,708 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2026-09-01 | 2026-09-02 | 2,098 | $5.53 | $11.6K | 10,708 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 23,742 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 10,362 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 10,362 | — | $0 | 10,362 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 11,463 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 11,463 | — | $0 | 11,463 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-02-20 | 2026-02-23 | 20,400 | — | $0 | 20,400 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2025-09-09 | 2025-09-11 | 17,600 | — | $0 | 17,600 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2025-05-28 | 2025-05-29 | 8,610 | $1.18 | $10.2K | 8,610 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 19,111 | — | $0 | 19,111 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2024-09-06 | 2024-09-10 | 14,100 | — | $0 | 14,100 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-06-19 | 2024-06-21 | 64,503 | — | $0 | 64,503 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2024-03-04 | 2024-03-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 23,742 | — | $0 | 23,742 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-16 | 10,362 | — | $0 | 10,362 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-05-05 | 2022-05-09 | 11,463 | — | $0 | 11,463 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2021-07-21 | 2021-07-22 | 75,000 | — | $0 | 75,000 | SEC↗ |